CP-GEP identifies high-risk T1a melanoma patients beyond established adverse features

Yu WY, Pazhava A, Weitemeyer MB, Hölmich LR, Johansson I, Olofsson Bagge R, Utikal J, Venna S, Jackson J, Amaral T, van Akkooi A, Kolodney MS, McArthur GA, Meves A. J Am Acad Dermatol. 1 Feb 2026; 94(2):661-663. doi: 10.1016/j.jaad.2025.10.036. PMID: 41093058. ^{TOP 1%}